Filing Details
- Accession Number:
- 0001209191-19-016822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 17:47:11
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 17:47:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400973 | F John Crowley | C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-01 | 10,763 | $3.19 | 678,844 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-01 | 8,770 | $3.82 | 687,614 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-01 | 467 | $6.45 | 688,081 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-01 | 4,618 | $12.97 | 683,463 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-03-01 | 15,382 | $13.79 | 668,081 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2019-03-01 | 10,763 | $0.00 | 10,763 | $3.19 |
| Common Stock | Stock Options (right to buy) | Disposition | 2019-03-01 | 8,770 | $0.00 | 8,770 | $3.82 |
| Common Stock | Stock Options (right to buy) | Disposition | 2019-03-01 | 467 | $0.00 | 467 | $6.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,209 | 2024-01-03 | No | 4 | M | Direct | |
| 0 | 2024-06-26 | No | 4 | M | Direct | |
| 0 | 2022-02-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 64,895 | Indirect | By Trust |
Footnotes
- The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $13.31. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.38 to $13.99. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- All of the options were fully vested and exercisable as of March 1, 2019
Billionaire Hedge Funds
